BioMAP® T Cell Autoimmune Panel

BioMAP® T Cell Autoimmune Panel


For autoimmune indications, the challenge is to design treatments that selectively reduce unwanted autoimmunityrelated injury without disrupting healthy immune function. Current models for studying candidate drugs, especially chemically-induced animal testing, rarely fully predict the effects a candidate drug will have in humans. The BioMAP T Cell Autoimmune Panel was created to more fully predict efficacy across a range of immune-related diseases in a format that is faster, higher throughput, and more clinically relevant than current methods.